MEXACOF-AM Ambroxol 15 mg Levocetirizine 2.5 mg Guaiphenesin 50 mg Menthol 1 mg Syrup 100 ML

MEXACOF-AM

MEXACOF-AM combines Ambroxol Hydrochloride, Levocetirizine Dihydrochloride, Guaiphenesin and Menthol in an oral syrup formulation for respiratory and cough care.

📋 COMPOSITION
Ambroxol Hydrochloride 15 mg, Levocetirizine Dihydrochloride 2.5 mg, Guaiphenesin 50 mg, Menthol 1 mg

💊 DOSAGE FORM
Syrup

📦 PACKAGING TYPE
Oral Syrup

🗃️ PACKAGING
100 ML

SKU: 5d1fc0410726 Categories: , , Tags: , , , , ,

Description

MEXACOF-AM is a combination oral syrup containing Ambroxol Hydrochloride 15 mg, Levocetirizine Dihydrochloride 2.5 mg, Guaiphenesin 50 mg and Menthol 1 mg. The formulation combines mucolytic, expectorant, antihistamine and soothing actions to support respiratory care where medically appropriate.

For related cough, cold and respiratory formulations, explore the Medhexa Pharma product range for additional pharmaceutical products and therapeutic segments.

Therapeutic Segment

Respiratory Care | Cough & Cold | Mucolytic | Expectorant | Antihistamine | Oral Syrup

Uses of MEXACOF-AM

MEXACOF-AM may be used as part of supportive respiratory treatment when prescribed or recommended by a healthcare professional. Its ingredients can help address mucus, cough-related respiratory discomfort and associated allergic symptoms.

The product may be considered for:

  • Productive cough associated with excessive or thick mucus.
  • Respiratory conditions involving mucus congestion.
  • Bronchitic conditions where mucus clearance is required.
  • Allergic symptoms such as sneezing, runny nose and nasal irritation associated with respiratory complaints.
  • Respiratory tract infections where symptomatic treatment is appropriate.
  • Bronchial asthma or COPD exacerbations only when specifically directed by a healthcare professional and as part of appropriate disease management.

Guaifenesin is an expectorant that helps loosen mucus and thin bronchial secretions, making coughs more productive. Levocetirizine is an H1-antihistamine indicated for allergic rhinitis and chronic idiopathic urticaria in its approved oral-solution formulations.

Note: MEXACOF-AM should not be considered a substitute for disease-specific treatment of asthma, COPD or serious respiratory infections.

Key Benefits of MEXACOF-AM

  • Combines four ingredients with complementary respiratory-care actions.
  • Ambroxol Hydrochloride supports mucus thinning and clearance.
  • Guaiphenesin helps loosen phlegm and thin bronchial secretions.
  • Levocetirizine Dihydrochloride helps manage histamine-related allergic symptoms.
  • Menthol provides a cooling and soothing sensation in the throat.
  • Supports symptomatic management of cough associated with mucus and respiratory discomfort.
  • May help provide relief when respiratory symptoms occur alongside allergic manifestations.
  • Convenient oral syrup formulation.
  • Supplied in a 100 ML pack.

How MEXACOF-AM Works

MEXACOF-AM combines ingredients that act through different mechanisms.

Ambroxol Hydrochloride is a mucolytic agent that helps reduce the viscosity of respiratory mucus, supporting easier mucus clearance.

Guaiphenesin acts as an expectorant. It helps loosen phlegm and thin bronchial secretions so that mucus can be cleared more effectively through coughing.

Levocetirizine Dihydrochloride blocks histamine H1 receptors and therefore helps reduce symptoms associated with histamine release, such as sneezing, runny nose and itching.

Menthol provides a cooling, soothing sensation that can help reduce the perception of throat irritation.

Together, these ingredients provide complementary support for respiratory symptoms involving mucus, cough and allergic discomfort.

Common Side Effects of MEXACOF-AM

Possible side effects can vary according to the individual ingredients and the patient’s sensitivity. They may include:

  • Nausea
  • Vomiting
  • Stomach discomfort
  • Diarrhoea
  • Headache
  • Dry mouth
  • Drowsiness or fatigue
  • Dizziness
  • Throat or mouth irritation

Levocetirizine can cause somnolence, fatigue and dry mouth in some patients.

If symptoms become severe, persistent or unusual, discontinue use only as medically advised and consult a healthcare professional.

Important Safety Information

MEXACOF-AM should be used according to the product label and healthcare professional’s advice.

  • Do not exceed the recommended dose.
  • Use an appropriate measuring device to measure the syrup accurately.
  • Do not use multiple cough, cold or allergy medicines together without checking their ingredients, as this can result in accidental duplication.
  • Patients with asthma, COPD, chronic bronchitis or persistent cough should consult a healthcare professional before using expectorant-based cough medicines. FDA labeling for guaifenesin specifically advises medical evaluation for persistent or chronic cough and cough associated with asthma, chronic bronchitis or emphysema.
  • Seek medical advice if cough persists for more than a week, repeatedly returns, or occurs with fever, rash, persistent headache or other concerning symptoms.
  • Levocetirizine may cause drowsiness or reduced alertness in some patients. Avoid driving or operating machinery if affected.
  • Avoid alcohol or other substances that can increase central nervous system depression when using levocetirizine.
  • Patients with kidney impairment should inform their healthcare professional because levocetirizine dosage may require adjustment.
  • Inform your doctor about pregnancy, breastfeeding, existing medical conditions and other medicines before use.
  • Keep the product out of reach of children.
  • Do not use the product after its expiry date.

For additional information on expectorant use and safety, healthcare professionals can refer to the FDA OTC cough and cold monograph.

Dosage & Administration

The dosage of MEXACOF-AM should follow the approved product label and the healthcare professional’s recommendation.

The supplied information does not specify whether the listed strengths are per 5 mL, per 10 mL or another measured volume, so the dose should not be calculated from the 100 ML bottle size or from the individual ingredient strengths alone.

  • Shake the syrup well before use if directed on the product label.
  • Measure each dose using a suitable measuring device.
  • Do not use a household spoon for accurate dosing.
  • Do not exceed the prescribed or labelled frequency.
  • Children should receive this combination only according to age-appropriate product directions and professional advice.

Storage

  • Store MEXACOF-AM according to the conditions stated on the product label.
  • Keep the bottle tightly closed when not in use.
  • Protect from excessive heat, moisture and direct sunlight.
  • Keep out of reach of children.
  • Do not use after the expiry date.
  • Follow the manufacturer’s instructions regarding storage after opening.

Additional information

Packing

Related products